18 results
6-K
EX-99.2
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
President Diabetes and Cardiovascular Global Business Unit. During his tenure at Sanofi, he held many senior positions including Vice President Eastern … of Directors The tenure of Dr. Rajesh Parekh and Dr. Mary Kerr as members of our Board of Directors came to an end during the financial year ended
6-K
EX-99.15
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
, as follows, during their tenure as Executive Committee member: Chief Executive Officer: two times annual gross base salary; and Other Executive Committee
6-K
EX-99.2
GLPG
Galapagos NV
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
tenure at Janssen Pharmaceutica (a J&J Company), and I am thrilled to have the opportunity to be a part of the Galapagos community and work alongside
6-K
EX-99.1
GLPG
Galapagos NV
15 Jun 23
Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
5:03pm
financial roles at various J&J locations in the US, China, Belgium, Russia, and Hungary. During his tenure at J&J, he helped establish the R&D
6-K
EX-99.1
pa2psqxyiq3k21k27y
13 Jun 23
Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board
7:53am
6-K
EX-99.1
r97bo6321dlzvm
2 May 23
Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer
4:49pm
6-K
EX-99.3
ilcm2w3an
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.2
xu2x9
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.1
1lbjl
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.4
9acnjntsdm 6qt
1 Apr 19
Current report (foreign)
12:00am
6-K
EX-99.1
2q38mxh7drjyt afm6
1 Apr 19
Current report (foreign)
12:00am
DRS
EX-10
d28tw8owb7ifmi36 oas
6 Feb 15
Draft registration statement
12:00am
- Prev
- 1
- Next